8,832
Total Claims
$609K
Drug Cost
706
Beneficiaries
$863
Cost/Patient
Peer Comparison vs. 106,889 Family Practice providers
-94%
Opioid rate vs peers
0.1% vs 2.6% avg
-19%
Cost per patient vs peers
$863 vs $1,068 avg
+20%
Brand preference vs peers
10.8% vs 9.0% avg
Opioid Prescribing
0.1%
Opioid Rate
13
Opioid Claims
$56
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
89% generic
Brand: 950 claims · $475K
Generic: 7,830 claims · $129K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 60 | $63K |
| Sitagliptin Phosphate | 36 | $52K |
| Empagliflozin | 26 | $31K |
| Linagliptin | 26 | $28K |
| Liraglutide | 23 | $27K |
| Insulin Glargine,hum.Rec.Anlog | 30 | $23K |
| Insulin Glargine,hum.Rec.Anlog | 44 | $18K |
| Sitagliptin Phos/Metformin Hcl | 15 | $14K |
| Linaclotide | 14 | $13K |
| Fluticasone Propionate | 34 | $11K |
| Fluticasone Propion/Salmeterol | 19 | $9,384 |
| Fluticasone Propion/Salmeterol | 18 | $8,788 |
| Dapagliflozin Propanediol | 13 | $7,606 |
| Insulin Aspart | 12 | $7,275 |
| Canagliflozin | 11 | $7,254 |
Prescribing Profile
Patient Profile
75
Avg Age
55%
Female
1.15
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About